PRME
Price
$3.24
Change
-$0.20 (-5.81%)
Updated
Aug 29 closing price
Capitalization
577.61M
61 days until earnings call
TERN
Price
$6.96
Change
-$0.11 (-1.56%)
Updated
Aug 29 closing price
Capitalization
609.08M
80 days until earnings call
Interact to see
Advertisement

PRME vs TERN

Header iconPRME vs TERN Comparison
Open Charts PRME vs TERNBanner chart's image
Prime Medicine
Price$3.24
Change-$0.20 (-5.81%)
Volume$3.04M
Capitalization577.61M
Terns Pharmaceuticals
Price$6.96
Change-$0.11 (-1.56%)
Volume$912.39K
Capitalization609.08M
PRME vs TERN Comparison Chart in %
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. TERN commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a Hold and TERN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (PRME: $3.24 vs. TERN: $6.96)
Brand notoriety: PRME and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 68% vs. TERN: 88%
Market capitalization -- PRME: $577.61M vs. TERN: $609.08M
PRME [@Biotechnology] is valued at $577.61M. TERN’s [@Biotechnology] market capitalization is $609.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, both PRME and TERN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 2 TA indicator(s) are bullish while TERN’s TA Score has 3 bullish TA indicator(s).

  • PRME’s TA Score: 2 bullish, 6 bearish.
  • TERN’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, TERN is a better buy in the short-term than PRME.

Price Growth

PRME (@Biotechnology) experienced а -8.73% price change this week, while TERN (@Biotechnology) price change was +0.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

PRME is expected to report earnings on Oct 31, 2025.

TERN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TERN($609M) has a higher market cap than PRME($578M). TERN YTD gains are higher at: 25.632 vs. PRME (10.959). TERN has higher annual earnings (EBITDA): -105M vs. PRME (-197.38M). TERN has more cash in the bank: 315M vs. PRME (102M). TERN has less debt than PRME: TERN (1.13M) vs PRME (120M). PRME has higher revenues than TERN: PRME (4.96M) vs TERN (0).
PRMETERNPRME / TERN
Capitalization578M609M95%
EBITDA-197.38M-105M188%
Gain YTD10.95925.63243%
P/E RatioN/AN/A-
Revenue4.96M0-
Total Cash102M315M32%
Total Debt120M1.13M10,591%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMETERN
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 27 days ago
79%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPESX5.390.01
+0.19%
Voya Large Cap Value Port S
LHCTX19.75-0.03
-0.15%
Lord Abbett Health Care R5
KCSIX13.87-0.06
-0.43%
Knights of Columbus Small Cap I
JGMNX28.73-0.16
-0.55%
Janus Henderson Triton N
CPODX59.01-0.34
-0.57%
Morgan Stanley Insight I

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with SYRE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
-1.56%
SYRE - TERN
49%
Loosely correlated
-1.38%
BEAM - TERN
47%
Loosely correlated
-2.91%
VRDN - TERN
45%
Loosely correlated
-0.33%
XNCR - TERN
45%
Loosely correlated
+0.99%
CRBU - TERN
44%
Loosely correlated
-3.61%
More